This Subcontract opportunity from Department Of Defense was posted on July 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Raw Material or API Supply for Lisinopril

Closed

Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325411

New

DIBBS

INFLUENZA VIRUS VACCIN

Solicitation # SPE2DP-27-T-0267

Solicitation SPE2DP-27-T-0267 is a fixed-price contract issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of FluBlok trivalent recombinant influenza virus vaccines for the 2026-2027 formula. The requirement is for 2 packages of 0.5 ML single-dose prefilled syringes, intended for immunizing persons 18 years of age and older. The product, manufactured by Sanofi Vaccines US Inc. (P/N NDC49281-0726-10), must be latex-free, preservative-free, and administered via intramuscular injection. Critical handling requirements include maintaining refrigeration between 2-8 degrees Celsius, protecting the vaccine from light, and ensuring it does not freeze. Delivery is specified as FOB Destination to AMC Bragg MM at Fort Bragg, NC, with an original required delivery date of November 9, 2026. Inspection and acceptance will occur at the destination per FAR 52.246-2. Packaging must be commercial and adhere to MIL-STD-2073-1E and RP001, with marking following Medical Marking Standard No. 1. The contract incorporates various DFARS and FAR clauses, including strict cybersecurity reporting under DFARS 252.204-7012, hazardous material identification, and compliance with the Buy American Act and Berry Amendment. All payment requests must be processed electronically through the Wide Area WorkFlow (WAWF) system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0254

Solicitation SPE2DP-27-T-0254 is a small business set-aside procurement issued by the Defense Logistics Agency for the acquisition of Magnesium Sulfate laxative in the form of 495MG/5GM oral granules. The requirement is for one case of 12 bags, each weighing 454GM. The item is classified as a TYPE I (CODE Q) product with a non-extendable shelf life of 36 months. Delivery is required FOB Destination to the USS Illinois (SSN 786) at the Naval Submarine Support Center in Pearl Harbor, Hawaii, with a required delivery date of November 9, 2026. Inspection and acceptance will occur at the destination. Packaging must be commercial and consist of suitable sealed unit containers and exterior shipping containers to prevent damage. Marking must strictly adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The contract incorporates several critical FAR and DFARS clauses, including requirements for safeguarding covered defense information, Buy American Act compliance, and the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and receiving reports. Quotations must be submitted via the DLA Internet Bid Board System (DIBBS) by November 12, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

High Char Yield Polymer Resin DevelopmentThis subcontract, issued by the NASA SBIR/STTR Program, focuses on the research, design, and synthesis of a novel polymer resin formulation. The primary technical objective is to develop a material capable of achieving a char yield exceeding 80 percent to facilitate the rapid manufacturing of carbon fiber–carbon matrix composites. The project is designated as a Total Small Business Set-Aside under the SBIR/STTR mandate, restricting eligibility to firms with fewer than 500 employees. Performance of the contract is centered in Huntsville, Alabama, and falls under NAICS code 325411 for polymer resin development.

NASA SBIR/STTR Program

POSTED

DEADLINE

Supply of Adhesive TapesThis subcontract, titled Supply of Adhesive Tapes, is issued by the Government of Jamaica under the JCA Project and Initiatives Implementation agency. The contractor is responsible for sourcing, packaging, and delivering various adhesive tapes that meet the specific requirements of the General Stores Unit for maintenance and utility purposes. The scope of work involves the supply and delivery of these materials to prime contractors working on JCA Project and Initiatives Implementation facility projects. The contract is categorized under NAICS code 325411 and was posted on August 20, 2026.

JCA Project and Initiatives Implementation

POSTED

DEADLINE

Supplier of Raw Active Pharmaceutical Ingredient (API) – DiazepamThe Defense Logistics Agency, under the Department of Defense, has established a subcontract for the supply of bulk Diazepam Active Pharmaceutical Ingredient. The material must adhere to USP standards to ensure suitability for the formulation of 5 mg tablets. The supplier is required to provide a Certificate of Analysis and necessary regulatory support to maintain compliance. This procurement falls under NAICS code 325411 and was posted on August 11, 2026.

Defense Logistics Agency

POSTED

DEADLINE

Supplier of Active Pharmaceutical Ingredient (API) – Promethazine HydrochlorideThe contract pertains to the supply of USP-grade promethazine hydrochloride active pharmaceutical ingredient for use in the final formulation of a pharmaceutical product, specifically under a subcontract arrangement. The procurement is managed by the Defense Logistics Agency within the Department of Defense, with the NAICS code 325411 indicating classification under pharmaceutical and biological product manufacturing. Although the solicitation number and specific point of contact are not provided, the posting date is August 9, 2026, and the performance location details are unspecified. The API must meet United States Pharmacopeia standards to ensure quality and compliance with regulatory requirements for drug manufacturing. The contract reference number SPE2DX25D8022 and delivery identifier SPE2D926F8075 are linked through the DIBBS system, facilitating tracking and award administration for the supplier.

Defense Logistics Agency

POSTED

DEADLINE

Insect Repellent Supply for DoD UseThe contract entails the supply of 20 boxes of insect repellent standardized under NSN 6840016567707 for use by the Department of Defense, ensuring full compliance with Defense Logistics Agency packaging and delivery specifications. The product is classified under NAICS code 325411, indicating its origin in the manufacturing of other chemical products, and is being procured as a subcontract under the broader defense supply chain. Delivery must adhere strictly to DLA standards to ensure operational readiness and compatibility with military logistics systems. The contract was posted on July 21, 2026, and is tied to the award contract SPE4AX16D9008 with delivery identifier SPE4A626FCWRC, though no specific location or point of contact is provided. The effort supports the Department of Defense's mission-critical need for pest protection in deployment environments.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Repackaging and Labeling ServicesThe contract involves the repackaging of fluconazole tablets into containers that meet Department of Defense compliance standards, ensuring proper military-specific labeling with National Stock Number, Technical Control Number, and military identification blocks. This work requires strict adherence to DoD packaging and labeling protocols to ensure accurate traceability, inventory control, and field distribution within military supply chains. The contractor must handle pharmaceuticals under appropriate conditions to maintain product integrity and regulatory compliance throughout the repackaging process. The performance of this subcontract falls under NAICS code 325411 for pharmaceutical and medicine manufacturing and is managed by the Defense Logistics Agency on behalf of the Department of Defense. While specific location details for performance or contact information are not provided, the contract is tied to a defined delivery and award mechanism through DLA’s procurement system, indicating it supports routine military pharmaceutical supply needs. The work is scheduled to be active following a public posting in July 2026, and the nature of the task suggests the contractor must possess experience in regulated pharmaceutical repackaging and familiarity with military logistical requirements.

Defense Logistics Agency

POSTED

DEADLINE

Manufacturer Sourcing for NDC-Specified ItemsThe contract authorizes the supply of surgical detergent exclusively from manufacturers holding active NDC listings and approved CAGE codes 1LZX9 or 3LDD7, ensuring strict federal compliance and integration into prime contract deliverables. This procurement is tightly regulated to maintain quality and regulatory standards within the Defense Logistics Agency’s supply chain, with all products required to meet mandated criteria for use in medical and surgical settings under Department of Defense requirements. The solicitation, classified as a subcontract under NAICS code 325411, is managed by the Defense Logistics Agency and was posted on July 17, 2026. While no specific place of performance or point of contact is provided, the contract is linked to prime contract deliverables and is accessible through the DIBBS system under contract SPE2DX25D9900 and delivery order SPE2DP26F7735, emphasizing its role in supporting federal medical logistics operations.

Defense Logistics Agency

POSTED

DEADLINE

Bulk Active Pharmaceutical Ingredient (API) SupplyThe contract entails the supply of bulk pseudoephedrine hydrochloride active pharmaceutical ingredient for use in the manufacturing of tablet formulations, with strict adherence to U.S. Food and Drug Administration and Drug Enforcement Administration regulations to ensure quality, security, and compliance with controlled substance standards. The agreement is structured as a subcontract under the Defense Logistics Agency, part of the Department of Defense, and falls under the NAICS code 325411 for pharmaceutical and biological product manufacturing. The supply must meet all federal requirements for handling, documentation, and tracking of this regulated substance, including chain-of-custody protocols and production controls. Performance is expected to support national pharmaceutical needs without specified geographic limitations, and the contract is linked to a specific procurement identifier under the DIBBS system, indicating formal award and tracking through official defense logistics channels.

Defense Logistics Agency

POSTED

DEADLINE

Manufacturer Sourcing & Supply Chain FulfillmentThe contract entails the procurement of Methocarbamol Tablets from manufacturers registered with the FDA and possessing approved CAGE codes specified within the agreement, ensuring compliance with regulatory and supply chain requirements. The sourcing effort is managed under the Defense Logistics Agency within the Department of Defense, focusing exclusively on FDA-registered producers to guarantee product safety, quality, and authenticity throughout the supply chain. All manufacturers must be pre-vetted and listed in the contract’s approved vendor database to qualify for fulfillment. This subcontract, classified under NAICS code 325411 for pharmaceutical and biological product manufacturing, is part of a broader initiative to secure essential medications for military and defense-related medical needs. The contract was posted on July 15, 2026, and is tied to the procurement number SPE2DP26F7703 under the primary contract SPE2DX25D9900, with performance activities centered on the logistical and supply chain infrastructure managed by the Defense Logistics Agency. The terms require strict adherence to regulatory standards, timely delivery, and traceability of all manufactured lots to ensure uninterrupted availability of Methocarbamol Tablets for authorized recipients.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Packaging and LabelingThe contract pertains to the packaging and labeling of Loperamide Hydrochloride in full compliance with military and regulatory standards, ensuring adherence to established identifiers including NSN, NDC, CAGE, and MarkFor codes with full traceability throughout the supply chain. This subcontract is issued under the Defense Logistics Agency’s Department of Defense authority and falls under the NAICS code 325411, which classifies pharmaceutical preparation manufacturing. The work must align with stringent federal specifications to support military medical logistics, requiring precise documentation and labeling to ensure accurate identification, distribution, and accountability of the product within defense health systems. The contract was posted on July 14, 2026, and is accessible via a dedicated DIBBS portal link for award and delivery records.

Defense Logistics Agency

POSTED

4 months ago

DEADLINE

N/A

AI Contract Overview

This subcontract, issued by the Defense Logistics Agency under the Department of Defense, concerns the procurement of Lisinopril in the form of either an Active Pharmaceutical Ingredient or finished tablets. The materials are intended for integration into a final product and must be sourced from manufacturers that are FDA-registered and compliant with current Good Manufacturing Practices. To ensure regulatory and administrative compliance, the supplier is required to provide a Drug Master File and a CAGE code. The contract falls under NAICS code 325411, focusing on the supply of pharmaceutical preparations to meet agency requirements.

General Info

DLA subcontract for FDA-registered Lisinopril API or tablets meeting pharmaceutical compliance standards.

Agency

Department Of Defense → Defense Logistics Agency

NAICS

325411 - Medicinal and Botanical Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Documents

This scope was carved out of SPE2D226F2924.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

LISINOPRIL TABLETS

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed

PostedJul 1

subcontract

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Logistics Agency

ContactsNo contacts available

OfficeN/A

Organization / AgencyDepartment Of Defense → Defense Logistics Agency

Office AddressN/A

ContactsNo contact information available

Full Description

Supply of Lisinopril Active Pharmaceutical Ingredient (API) or finished tablets from FDA-registered, cGMP-compliant manufacturers with DMF and CAGE code for integration into final product.